Improved pulse wave velocity and renal function in individualized calcineurin inhibitor treatment by immunomonitoring: the randomized controlled calcineurin inhibitor-sparing trial
BACKGROUND: A new immune monitoring tool which assesses the expression of nuclear factor of activated T cells (NFAT)-regulated genes measures the functional effects of cyclosporine A. This is the first prospective randomized controlled study to compare standard pharmacokinetic monitoring by cyclospo...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 2018
|
| In: |
Transplantation
Year: 2018, Jahrgang: 102, Heft: 3, Pages: 510-520 |
| ISSN: | 1534-6080 |
| DOI: | 10.1097/TP.0000000000001973 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/TP.0000000000001973
|
| Verfasserangaben: | Claudia Sommerer, Janina Brocke, Thomas Bruckner, Matthias Schaier, Christian Morath, Stefan Meuer, Martin Zeier, Thomas Giese |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1693414317 | ||
| 003 | DE-627 | ||
| 005 | 20230427033647.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200327s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/TP.0000000000001973 |2 doi | |
| 035 | |a (DE-627)1693414317 | ||
| 035 | |a (DE-599)KXP1693414317 | ||
| 035 | |a (OCoLC)1341311222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sommerer, Claudia |d 1971- |e VerfasserIn |0 (DE-588)121857654 |0 (DE-627)705680002 |0 (DE-576)292921829 |4 aut | |
| 245 | 1 | 0 | |a Improved pulse wave velocity and renal function in individualized calcineurin inhibitor treatment by immunomonitoring |b the randomized controlled calcineurin inhibitor-sparing trial |c Claudia Sommerer, Janina Brocke, Thomas Bruckner, Matthias Schaier, Christian Morath, Stefan Meuer, Martin Zeier, Thomas Giese |
| 264 | 1 | |c March 2018 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.03.2020 | ||
| 520 | |a BACKGROUND: A new immune monitoring tool which assesses the expression of nuclear factor of activated T cells (NFAT)-regulated genes measures the functional effects of cyclosporine A. This is the first prospective randomized controlled study to compare standard pharmacokinetic monitoring by cyclosporine trough levels to NFAT-regulated gene expression (NFAT-RE). - METHODS: Expression of the NFAT-regulated genes was determined by qRT-PCR at cyclosporine trough and peak level. Cardiovascular risk was assessed by change of pulse wave velocity from baseline to month 6. Clinical follow-up was 12 months. - RESULTS: In total, 55 stable kidney allograft recipients were enrolled. Mean baseline residual NFAT-RE was 13.1 ± 9.1%. Patients in the NFAT-RE group showed a significant decline in pulse wave velocity from baseline to month 6 versus the standard group (-1.7 ± 2.0 m/s vs 0.4 ± 1.4 m/s, P < 0.001). Infections occurred more often in the standard group compared with the immune monitoring group. No opportunistic infections occurred with NFAT-RE monitoring. At 12 months of follow-up, renal function was significantly better with NFAT-RE versus standard monitoring (Nankivell glomerular filtration rate: 68.5 ± 17.4 mL/min vs 57.2 ± 19.0 mL/min; P = 0.009). - CONCLUSIONS: NFAT-RE as translational immune monitoring tool proved efficacious and safe in individualizing cyclosporine therapy, with the opportunity to reduce the cardiovascular risk and improve long-term renal allograft function. | ||
| 650 | 4 | |a Calcineurin Inhibitors | |
| 650 | 4 | |a Cardiovascular Diseases | |
| 650 | 4 | |a Cyclosporine | |
| 650 | 4 | |a Glomerular Filtration Rate | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Kidney Transplantation | |
| 650 | 4 | |a NFATC Transcription Factors | |
| 650 | 4 | |a Prospective Studies | |
| 650 | 4 | |a Pulse Wave Analysis | |
| 700 | 1 | |a Brocke, Janina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bruckner, Thomas |d 1956- |e VerfasserIn |0 (DE-588)136046215 |0 (DE-627)574429298 |0 (DE-576)300798768 |4 aut | |
| 700 | 1 | |a Schaier, Matthias |d 1975- |e VerfasserIn |0 (DE-588)129029009 |0 (DE-627)387780335 |0 (DE-576)297455788 |4 aut | |
| 700 | 1 | |a Morath, Christian |d 1973- |e VerfasserIn |0 (DE-588)124036155 |0 (DE-627)085595837 |0 (DE-576)293989923 |4 aut | |
| 700 | 1 | |a Meuer, Stefan |d 1951- |e VerfasserIn |0 (DE-588)1020440198 |0 (DE-627)691221286 |0 (DE-576)360422454 |4 aut | |
| 700 | 1 | |a Zeier, Martin |e VerfasserIn |0 (DE-588)1026480302 |0 (DE-627)726772356 |0 (DE-576)371826438 |4 aut | |
| 700 | 1 | |a Giese, Thomas |d 1962- |e VerfasserIn |0 (DE-588)143133543 |0 (DE-627)704399075 |0 (DE-576)333724496 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transplantation |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1963 |g 102(2018), 3, Seite 510-520 |h Online-Ressource |w (DE-627)32529738X |w (DE-600)2035395-9 |w (DE-576)097188794 |x 1534-6080 |7 nnas |a Improved pulse wave velocity and renal function in individualized calcineurin inhibitor treatment by immunomonitoring the randomized controlled calcineurin inhibitor-sparing trial |
| 773 | 1 | 8 | |g volume:102 |g year:2018 |g number:3 |g pages:510-520 |g extent:11 |a Improved pulse wave velocity and renal function in individualized calcineurin inhibitor treatment by immunomonitoring the randomized controlled calcineurin inhibitor-sparing trial |
| 856 | 4 | 0 | |u https://doi.org/10.1097/TP.0000000000001973 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200327 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 143133543 |a Giese, Thomas |m 143133543:Giese, Thomas |d 910000 |d 911600 |e 910000PG143133543 |e 911600PG143133543 |k 0/910000/ |k 1/910000/911600/ |p 8 |y j | ||
| 998 | |g 1026480302 |a Zeier, Martin |m 1026480302:Zeier, Martin |d 910000 |d 910100 |e 910000PZ1026480302 |e 910100PZ1026480302 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1020440198 |a Meuer, Stefan |m 1020440198:Meuer, Stefan |d 910000 |d 911600 |e 910000PM1020440198 |e 911600PM1020440198 |k 0/910000/ |k 1/910000/911600/ |p 6 | ||
| 998 | |g 124036155 |a Morath, Christian |m 124036155:Morath, Christian |d 50000 |e 50000PM124036155 |k 0/50000/ |p 5 | ||
| 998 | |g 129029009 |a Schaier, Matthias |m 129029009:Schaier, Matthias |d 50000 |e 50000PS129029009 |k 0/50000/ |p 4 | ||
| 998 | |g 136046215 |a Bruckner, Thomas |m 136046215:Bruckner, Thomas |d 910000 |d 999701 |e 910000PB136046215 |e 999701PB136046215 |k 0/910000/ |k 1/910000/999701/ |p 3 | ||
| 998 | |g 121857654 |a Sommerer, Claudia |m 121857654:Sommerer, Claudia |d 50000 |e 50000PS121857654 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1693414317 |e 3614718476 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 27.03.2020"],"recId":"1693414317","name":{"displayForm":["Claudia Sommerer, Janina Brocke, Thomas Bruckner, Matthias Schaier, Christian Morath, Stefan Meuer, Martin Zeier, Thomas Giese"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"March 2018"}],"id":{"doi":["10.1097/TP.0000000000001973"],"eki":["1693414317"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"disp":"Improved pulse wave velocity and renal function in individualized calcineurin inhibitor treatment by immunomonitoring the randomized controlled calcineurin inhibitor-sparing trialTransplantation","pubHistory":["1.1963 -"],"note":["Gesehen am 11.06.2019"],"recId":"32529738X","type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"Transplantation Society","role":"isb"}],"id":{"issn":["1534-6080"],"zdb":["2035395-9"],"eki":["32529738X"]},"language":["eng"],"origin":[{"publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1963-","dateIssuedKey":"1963","publisher":"Lippincott Williams & Wilkins ; Ovid"}],"part":{"extent":"11","year":"2018","issue":"3","volume":"102","text":"102(2018), 3, Seite 510-520","pages":"510-520"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"the official journal of the Transplantation Society","title":"Transplantation","title_sort":"Transplantation"}]}],"person":[{"given":"Claudia","display":"Sommerer, Claudia","family":"Sommerer","role":"aut"},{"family":"Brocke","display":"Brocke, Janina","given":"Janina","role":"aut"},{"display":"Bruckner, Thomas","family":"Bruckner","given":"Thomas","role":"aut"},{"given":"Matthias","family":"Schaier","display":"Schaier, Matthias","role":"aut"},{"family":"Morath","display":"Morath, Christian","given":"Christian","role":"aut"},{"role":"aut","given":"Stefan","display":"Meuer, Stefan","family":"Meuer"},{"role":"aut","display":"Zeier, Martin","family":"Zeier","given":"Martin"},{"given":"Thomas","display":"Giese, Thomas","family":"Giese","role":"aut"}],"physDesc":[{"extent":"11 S."}],"title":[{"title_sort":"Improved pulse wave velocity and renal function in individualized calcineurin inhibitor treatment by immunomonitoring","subtitle":"the randomized controlled calcineurin inhibitor-sparing trial","title":"Improved pulse wave velocity and renal function in individualized calcineurin inhibitor treatment by immunomonitoring"}]} | ||
| SRT | |a SOMMERERCLIMPROVEDPU2018 | ||